Literature DB >> 25038147

Dantrolene suppresses spontaneous Ca2+ release without altering excitation-contraction coupling in cardiomyocytes of aged mice.

Timothy L Domeier1, Cale J Roberts2, Anne K Gibson2, Laurin M Hanft2, Kerry S McDonald2, Steven S Segal3.   

Abstract

Cardiac dysfunction in the aged heart reflects abnormalities in cardiomyocyte Ca(2+) homeostasis including altered Ca(2+) cycling through the sarcoplasmic reticulum (SR). The ryanodine receptor antagonist dantrolene exerts antiarrhythmic effects by preventing spontaneous diastolic Ca(2+) release from the SR. We tested the hypothesis that dantrolene prevents spontaneous Ca(2+) release without altering excitation-contraction coupling in aged myocardium. Left ventricular cardiomyocytes isolated from young (3 to 4 mo) and aged (24-26 mo) C57BL/6 mice were loaded with the Ca(2+) indicator fluo-4. Amplitudes of action potential-induced Ca(2+) transients at 1-Hz pacing were similar between young and aged mice, yet cell shortening was impaired in aged mice. Isoproterenol (1 μM) increased Ca(2+) transient amplitude and cell shortening to identical levels in young and aged; dantrolene (1 μM) had no effect on Ca(2+) transients or cell shortening during pacing. Under Ca(2+) overload conditions induced with 10 mM extracellular Ca(2+) concentration, spontaneous Ca(2+) waves were of diminished amplitude and associated with lower SR Ca(2+) content in aged versus young mice. Despite no effect in young mice, dantrolene increased SR Ca(2+) content and Ca(2+) wave amplitude in aged mice. In the presence of isoproterenol following rest from 1-Hz pacing, Ca(2+) spark frequency was elevated in aged mice, yet the time to spontaneous Ca(2+) wave was similar between young and aged mice; dantrolene decreased Ca(2+) spark frequency and prolonged the time to Ca(2+) wave onset in aged mice with no effect in young mice. Thus dantrolene attenuates diastolic Ca(2+) release in the aged murine heart that may prove useful in preventing cardiac dysfunction.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  Ca2+ sparks; Ca2+ waves; aging; heart; ventricular myocytes

Mesh:

Substances:

Year:  2014        PMID: 25038147      PMCID: PMC4166750          DOI: 10.1152/ajpheart.00287.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  64 in total

1.  Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required.

Authors:  Luigi A Venetucci; Andrew W Trafford; David A Eisner
Journal:  Circ Res       Date:  2006-11-16       Impact factor: 17.367

2.  SparkMaster: automated calcium spark analysis with ImageJ.

Authors:  Eckard Picht; Aleksey V Zima; Lothar A Blatter; Donald M Bers
Journal:  Am J Physiol Cell Physiol       Date:  2007-03-21       Impact factor: 4.249

3.  Cardiac excitation-contraction coupling is altered in myocytes from aged male mice but not in cells from aged female mice.

Authors:  Scott A Grandy; Susan E Howlett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-26       Impact factor: 4.733

4.  A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.

Authors:  Jeffrey R Erickson; Mei-ling A Joiner; Xiaoqun Guan; William Kutschke; Jinying Yang; Carmine V Oddis; Ryan K Bartlett; John S Lowe; Susan E O'Donnell; Nukhet Aykin-Burns; Matthew C Zimmerman; Kathy Zimmerman; Amy-Joan L Ham; Robert M Weiss; Douglas R Spitz; Madeline A Shea; Roger J Colbran; Peter J Mohler; Mark E Anderson
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

5.  Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.

Authors:  Daniel R Gonzalez; Farideh Beigi; Adriana V Treuer; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

Review 6.  The sarcoplasmic reticulum and arrhythmogenic calcium release.

Authors:  Luigi A Venetucci; Andrew W Trafford; Stephen C O'Neill; David A Eisner
Journal:  Cardiovasc Res       Date:  2007-09-13       Impact factor: 10.787

7.  The effects of isoproterenol on abnormal electrical and contractile activity and diastolic calcium are attenuated in myocytes from aged Fischer 344 rats.

Authors:  Spring R Farrell; Susan E Howlett
Journal:  Mech Ageing Dev       Date:  2007-08-17       Impact factor: 5.432

8.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.

Authors:  Hiroshi Watanabe; Nagesh Chopra; Derek Laver; Hyun Seok Hwang; Sean S Davies; Daniel E Roach; Henry J Duff; Dan M Roden; Arthur A M Wilde; Björn C Knollmann
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440

9.  Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.

Authors:  Shigeki Kobayashi; Masafumi Yano; Takeshi Suetomi; Makoto Ono; Hiroki Tateishi; Mamoru Mochizuki; Xiaojuan Xu; Hitoshi Uchinoumi; Shinichi Okuda; Takeshi Yamamoto; Noritaka Koseki; Hiroyuki Kyushiki; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  J Am Coll Cardiol       Date:  2009-05-26       Impact factor: 24.094

10.  Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure.

Authors:  Dmitry Terentyev; Inna Györke; Andriy E Belevych; Radmila Terentyeva; Arun Sridhar; Yoshinori Nishijima; Esperanza Carcache de Blanco; Savita Khanna; Chandan K Sen; Arturo J Cardounel; Cynthia A Carnes; Sandor Györke
Journal:  Circ Res       Date:  2008-11-13       Impact factor: 17.367

View more
  7 in total

1.  Reduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease.

Authors:  Wenqian Chen; Andrea Koop; Yingjie Liu; Wenting Guo; Jinhong Wei; Ruiwu Wang; David H MacLennan; Robert T Dirksen; Sui Rong Wayne Chen
Journal:  Biochem J       Date:  2017-08-07       Impact factor: 3.857

Review 2.  Cardiomyocyte Ca2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction.

Authors:  Deborah Peana; Timothy L Domeier
Journal:  Curr Opin Pharmacol       Date:  2017-04-22       Impact factor: 5.547

3.  TRPV4 increases cardiomyocyte calcium cycling and contractility yet contributes to damage in the aged heart following hypoosmotic stress.

Authors:  John L Jones; Deborah Peana; Adam B Veteto; Michelle D Lambert; Zahra Nourian; Natalia G Karasseva; Michael A Hill; Brian R Lindman; Christopher P Baines; Maike Krenz; Timothy L Domeier
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

4.  Arrhythmogenesis in the aged heart following ischaemia-reperfusion: role of transient receptor potential vanilloid 4.

Authors:  Deborah Peana; Luis Polo-Parada; Timothy L Domeier
Journal:  Cardiovasc Res       Date:  2022-03-16       Impact factor: 13.081

5.  Functional recovery after dantrolene-supplementation of cold stored hearts using an ex vivo isolated working rat heart model.

Authors:  Jeanette E Villanueva; Ling Gao; Hong C Chew; Mark Hicks; Aoife Doyle; Min Ru Qui; Kumud K Dhital; Peter S Macdonald; Andrew Jabbour
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

6.  Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice.

Authors:  Mohammed Ali Azam; Praloy Chakraborty; Mahmoud M Bokhari; Keith Dadson; Beibei Du; Stéphane Massé; Daoyuan Si; Ahmed Niri; Arjun K Aggarwal; Patrick F H Lai; Sheila Riazi; Filio Billia; Kumaraswamy Nanthakumar
Journal:  Heart Rhythm O2       Date:  2021-12-17

7.  Ageing-associated increase in SGLT2 disrupts mitochondrial/sarcoplasmic reticulum Ca2+ homeostasis and promotes cardiac dysfunction.

Authors:  Yusuf Olgar; Erkan Tuncay; Sinan Degirmenci; Deniz Billur; Rimpy Dhingra; Lorrie Kirshenbaum; Belma Turan
Journal:  J Cell Mol Med       Date:  2020-07-11       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.